Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteers

被引:94
作者
Keenan, Alison H. [1 ]
Pedersen, Theresa L. [2 ]
Fillaus, Kristi [3 ]
Larson, Mark K. [4 ]
Shearer, Gregory C. [3 ,5 ]
Newman, John W. [1 ,2 ]
机构
[1] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA
[2] ARS, Western Human Nutr Res Ctr, Davis, CA 95616 USA
[3] Univ S Dakota, Sanford Res, Cardiovasc Hlth Res Ctr, Sioux Falls, SD 57117 USA
[4] Augustana Coll, Dept Biol, Sioux Falls, SD 57197 USA
[5] Univ S Dakota, Sanford Sch Med, Vermillion, SD 57069 USA
基金
美国食品与农业研究所;
关键词
omega-3 fatty acids; oxylipins; targeted metabolomics; baseline status; highly unsaturated fatty acid; CORONARY-HEART-DISEASE; EPOXYEICOSATRIENOIC ACIDS; OMEGA-3; INDEX; ETHYL-ESTERS; DOCOSAHEXAENOIC ACID; CARDIOVASCULAR-DISEASE; EICOSAPENTAENOIC ACID; ARACHIDONIC-ACID; RISK-FACTOR; INFLAMMATION;
D O I
10.1194/jlr.P025577
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A subject's baseline FA composition may influence the ability of dietary highly unsaturated omega-3 FAs (n3-HUFA) to change circulating profiles of esterified FAs and their oxygenated metabolites. This study evaluates the influence of basal n3-HUFA and n3-oxylipin status on the magnitude of response to n3-HUFA consumption. Blood was collected from fasting subjects (n = 30) before and after treatment (4 weeks; 11 +/- 2 mg/kg/day n3-HUFA ethyl esters). Esterified FAs were quantified in erythrocytes, platelets, and plasma by GC-MS. Esterified oxylipins were quantified in plasma by LC-MS/MS. Treatment with n3-HUFAs increased n3-HUFAs and decreased n6-HUFAs in all reservoirs and increased plasma n3-oxylipins without significantly changing n6-oxylipin concentrations. As subject basal n3-HUFAs increased, treatment-associated changes decreased, and this behavior was reflected in the percentage of 20:5n3 + 22:6n3 in red blood cell membrane FAs (i.e., the omega-3 index). To maintain an omega-3 index of 8% and thus reduce cardiovascular disease risk, our analyses suggest a maintenance dose of 7 mg/kg/day n3-HUFA ethyl esters for a 70-kg individual.(jlr) These results suggest that the basal n3 index may have clinical utility to establish efficacious therapeutic experimental feeding regimens and to evaluate the USDA Dietary Guidelines recommendations for n3-HUFA consumption.-Keenan, A. H., T. L. Pedersen, K.i Fillaus, M. K. Larson, G. C. Shearer, and J. W. Newman. Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteers. J. Lipid Res. 2012. 53: 1662-1669.
引用
收藏
页码:1662 / 1669
页数:8
相关论文
共 52 条
[11]   Omega-3 polyunsaturated fatty acids and human health outcomes [J].
Calder, Philip C. ;
Yaqoob, Parveen .
BIOFACTORS, 2009, 35 (03) :266-272
[12]   Subgram daily supplementation with docosahexaenoic acid protects low-density lipoproteins from oxidation in healthy men [J].
Calzada, Catherine ;
Colas, Romain ;
Guillot, Nicolas ;
Guichardant, Michel ;
Laville, Martine ;
Vericel, Evelyne ;
Lagarde, Michel .
ATHEROSCLEROSIS, 2010, 208 (02) :467-472
[13]   THE EFFECTS OF DIETARY OMEGA-3 POLY-UNSATURATED FATTY-ACIDS ON ERYTHROCYTE-MEMBRANE PHOSPHOLIPIDS, ERYTHROCYTE DEFORMABILITY AND BLOOD-VISCOSITY IN HEALTHY-VOLUNTEERS [J].
CARTWRIGHT, IJ ;
POCKLEY, AG ;
GALLOWAY, JH ;
GREAVES, M ;
PRESTON, FE .
ATHEROSCLEROSIS, 1985, 55 (03) :267-281
[14]   Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study [J].
Davidson, Michael H. ;
Stein, Evan A. ;
Bays, Harold E. ;
Maki, Kevin C. ;
Doyle, Ralph T. ;
Shalwitz, Robert A. ;
Ballantyne, Christie M. ;
Ginsberg, Henry N. .
CLINICAL THERAPEUTICS, 2007, 29 (07) :1354-1367
[15]   n-3 fatty acids and gene expression [J].
Deckelbaum, Richard J. ;
Worgall, Tilla S. ;
Seo, Toru .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 83 (06) :1520S-1525S
[16]   Omega-6 fatty acids and coronary artery disease: The pros and cons [J].
Dubnov G. ;
Berry E.M. .
Current Atherosclerosis Reports, 2004, 6 (6) :441-446
[17]   Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity [J].
Ebrahimi, Mahmoud ;
Ghayour-Mobarhan, Majid ;
Rezaiean, Samaneh ;
Hoseini, Maryam ;
Parizade, Seyyed Mohamad Reza ;
Farhoudi, Fatemeh ;
Hosseininezhad, Syyed Javad ;
Tavallaei, Shima ;
Vejdani, Amirhosein ;
Azimi-Nezhad, Mohsen ;
Shakeri, Mohamad Taghi ;
Rad, Mina Akbari ;
Mobarra, Naser ;
Kazemi-Bajestani, Seyyed Mohammad Reza ;
Ferns, Gordon A. A. .
ACTA CARDIOLOGICA, 2009, 64 (03) :321-327
[18]  
ELBOUSTANI S, 1987, LIPIDS, V22, P711, DOI 10.1007/BF02533970
[19]   Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators:: protectin D1 and 17S-hydroxy-DHA [J].
Gonzalez-Periz, Ana ;
Planaguma, Anna ;
Gronert, Karsten ;
Miquel, Rosa ;
Lopez-Parra, Marta ;
Titos, Esther ;
Horrillo, Raquel ;
Ferre, Natalia ;
Deulofeu, Ramon ;
Arroyo, Vicente ;
Rodes, Juan ;
Claria, Joan .
FASEB JOURNAL, 2006, 20 (14) :2537-+
[20]  
GOODNIGHT SH, 1981, BLOOD, V58, P880